Cyclic di-GMP stimulates biofilm formation and inhibits virulence of francisella novicida

Infection and Immunity

Volumn 80, Issue 12, 2012, Pages 4239-4247

  Zogaj, Xhavit ^a   Wyatt, Geoff C ^a   Klose, Karl E ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHITINASE; CYCLIC DI GUANOSINE PHOSPHATE; CYCLIC GMP DERIVATIVE; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BIOFILM; CONTROLLED STUDY; FEMALE; FRANCISELLA NOVICIDA; GENE CLUSTER; GENE EXPRESSION; GRAM NEGATIVE AEROBIC RODS AND COCCI; IN VITRO STUDY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BACTERIAL PROTEINS; BIOFILMS; CHITINASE; CYCLIC GMP; FEMALE; FRANCISELLA; GENE EXPRESSION REGULATION, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEQUENCE ANALYSIS, DNA; VIRULENCE;

EID: 84870780690     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00702-12     Document Type: Article

References (50)

1. Barends TR, et al. 2009. Structure and mechanism of a bacterial light-regulated cyclic nucleotide phosphodiesterase. Nature 459:1015-1018.
2. Barker JR, et al. 2009. The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence. Mol. Microbiol. 74:1459-1470.
3. Beyhan S, Odell LS, Yildiz FH. 2008. Identification and characterization of cyclic diguanylate signalling systems controlling rugosity in Vibrio cholerae. J. Bacteriol. 190:7392-7405.
4. Beyhan S, Tischler AD, Camilli A, Yildiz FH. 2006. Transcriptome and phenotypic responses of Vibrio cholerae to increased cyclic di-GMP level. J. Bacteriol. 188:3600-3613.
5. Beyhan S, Yildiz FH. 2007. Smooth to rugose phase variation in Vibrio cholerae can be mediated by a single nucleotide change that targets c-di-GMP signalling pathway. Mol. Microbiol. 63:995-1007.
6. Chamberlain RE. 1965. Evaluation of live tularemia vaccine prepared in a chemically defined medium. Appl. Microbiol. 13:232-235.
7. Champion MD, et al. 2009. Comparative genomic characterization of Francisella tularensis strains belonging to low and high virulence subspecies. PLoS Pathog. 5:e1000459. doi:10.1371/journal.ppat.1000459.
8. Chandler JC, Molins CR, Petersen JM, Belisle JT. 2011. Differential chitinase activity and production within Francisella species, subspecies, and subpopulations. J. Bacteriol. 193:3265-3275.
9. Dennis DT, et al. 2001. Tularemia as a biological weapon: medical and public health management. JAMA 285:2763-2773.
10. Durham-Colleran MW, Verhoeven AB, van Hoek ML. 2010. Francisella novicida forms in vitro biofilms mediated by an orphan response regulator. Microb. Ecol. 59:457-465.
11. Eigelsbach HT, Downs CM. 1961. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J. Immunol. 87:415-425.
12. Ellis J, Oyston PC, Green M, Titball RW. 2002. Tularemia. Clin. Micro-biol. Rev. 15:631-646.
13. Gallagher LA, et al. 2007. A comprehensive transposon mutant library of Francisella novicida, a bioweapon surrogate. Proc. Natl. Acad. Sci. U. S.A. 104:1009-1014.
14. Guvener ZT, Harwood CS. 2007. Subcellular location characteristics of the Pseudomonas aeruginosa GGDEF protein, WspR, indicate that it produces cyclic-di-GMP in response to growth on surfaces. Mol. Microbiol. 66:1459-1473.
15. Hanahan D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:577-580.
16. Hecht GB, Newton A. 1995. Identification of a novel response regulator required for the swarmer-to-stalked-cell transition in Caulobacter cres-centus. J. Bacteriol. 177:6223-6229.
17. Hengge R. 2009. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol. 7:263-273.
18. Hickman JW, Tifrea DF, Harwood CS. 2005. A chemosensory system that regulates biofilm formation through modulation of cyclic diguanylate levels. Proc. Natl. Acad. Sci. U. S. A. 102:14422-14427.
19. Jenal U. 2004. Cyclic di-guanosine-monophosphate comes of age: a novel secondary messenger involved in modulating cell surface structures in bacteria? Curr. Opin. Microbiol. 7:185-191.
20. Jenal U, Malone J. 2006. Mechanisms of cyclic-di-GMP signaling in bacteria. Annu. Rev. Genet. 40:385-407.
21. Larsson P, et al. 2005. The complete genome sequence of Francisella tularensis, the causative agent of tularemia. Nat. Genet. 37:153-159.
22. Lauriano CM, Barker JR, Nano FE, Arulanandam BP, Klose KE. 2003. Allelic exchange in Francisella tularensis using PCR products. FEMS Microbiol. Lett. 229:195-202.
23. Lauriano CM, et al. 2004. MglA regulates transcription of virulence factors necessary for Francisella tularensis intraamoebae and intramacrophage survival. Proc. Natl. Acad. Sci. U. S. A. 101:4246-4249.
24. Liu J, Zogaj X, Barker JR, Klose KE. 2007. Construction of targeted insertion mutations in Francisella tularensis subsp. novicida. Biotechniques 43:487-490.
25. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
26. Margolis JJ, et al. 2010. Contributions of Francisella tularensis subsp. novicida chitinases and Sec secretion system to biofilm formation on chitin. Appl. Environ. Microbiol. 76:596-608.
27. Minasov G, et al. 2009. Crystal structures of YkuI and its complex with second messenger cyclic di-GMP suggest catalytic mechanism of phosphodiester bond cleavage by EAL domains. J. Biol. Chem. 284:13174-13184.
28. Moscoso JA, Mikkelsen H, Heeb S, Williams P, Filloux A. 2011. The Pseudomonas aeruginosa sensor RetS switches type III and type VI secretion via c-di-GMP signalling. Environ. Microbiol. 13:3128-3138.
29. Nano FE, et al. 2004. A Francisella tularensis pathogenicity island required for intramacrophage growth. J. Bacteriol. 186:6430-6436.
30. Oyston PC. 2008. Francisella tularensis: unravelling the secrets of an intracellular pathogen. J. Med. Microbiol. 57:921-930.
31. Paul R, et al. 2004. Cell cycle-dependent dynamic localization of a bacterial response regulator with a novel di-guanylate cyclase output domain. Genes Dev. 18:715-727.
32. Rao F, et al. 2009. The functional role of a conserved loop in EAL domainbased cyclic di-GMP-specific phosphodiesterase. J. Bacteriol. 191:4722-4731.
33. Rao F, Yang Y, Qi Y, Liang ZX. 2008. Catalytic mechanism of cyclic di-GMP-specific phosphodiesterase: a study of the EAL domaincontaining RocR from Pseudomonas aeruginosa. J. Bacteriol. 190:3622-3631.
34. Reif KE, et al. 2011. Dermacentor andersoni transmission of Francisella tularensis subsp. novicida reflects bacterial colonization, dissemination, and replication coordinated with tick feeding. Infect. Immun. 79:4941-4946.
35. Rohmer L, et al. 2007. Comparison of Francisella tularensis genomes reveals evolutionary events associated with the emergence of human pathogenic strains. Genome Biol. 8:R102.
36. Saslaw S, Carlisle HN. 1961. Studies with tularemia vaccines in volunteers. IV. Brucella aggiutinins in vaccinated and nonvaccinated volunteers challenged with Pasteurella tularensis. Am. J. Med. Sci. 242:166-172.
37. Schmidt AJ, Ryjenkov DA, Gomelsky M. 2005. The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J. Bacteriol. 187:4774-4781.
38. Shen H, Chen W, Conlan JW. 2004. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. Vaccine 22:2116-2121.
39. Siddaramappa S, et al. 2011. Common ancestry and novel genetic traits of Francisella novicida-like isolates from North America and Australia as revealed by comparative genomic analyses. Appl. Environ. Microbiol. 77:5110-5122.
40. Soding J, Biegert A, Lupas AN. 2005. The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res.33:W244-W248.
41. Tamayo R, Pratt JT, Camilli A. 2007. Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. Annu. Rev. Microbiol. 61:131-148.
42. Tamayo R, Tischler AD, Camilli A. 2005. The EAL domain protein VieA is a cyclic diguanylate phosphodiesterase. J. Biol. Chem. 280:33324-33330.
43. Tarnvik A, Berglund L. 2003. Tularaemia. Eur. Respir. J. 21:361-373.
44. Tarnvik A, Ericsson M, Golovliov I, Sandstrom G, Sjostedt A. 1996. Orchestration of the protective immune response to intracellular bacteria: Francisella tularensis as a model organism. FEMS Immunol. Med. Microbiol.13:221-225.
45. Tischler AD, Camilli A. 2004. Cyclic diguanylate (c-di-GMP) regulates Vibrio cholerae biofilm formation. Mol. Microbiol. 53:857-869.
46. Tischler AD, Camilli A. 2005. Cyclic diguanylate regulates Vibrio cholerae virulence gene expression. Infect. Immun. 73:5873-5882.
47. Titball RW, Petrosino JF. 2007. Francisella tularensis genomics and proteomics. Ann. N. Y. Acad. Sci. 1105:98-121.
48. Yang CY, et al. 2011. The structure and inhibition of a GGDEF diguanylate cyclase complexed with (c-di-GMP)(2) at the active site. Acta Crystallogr. D Biol. Crystallogr. 67:997-1008.
49. Yildiz FH, Schoolnik GK. 1999. Vibrio cholerae O1 El Tor: identification of a gene cluster required for the rugose colony type, exopolysaccharide production, chlorine resistance, and biofilm formation. Proc. Natl. Acad. Sci. U. S. A. 96:4028-4033.
50. Zogaj X, Chakraborty S, Liu J, Thanassi DG, Klose KE. 2008. Characterization of the Francisella tularensis subsp. novicida type IV pilus. Microbiology 154:2139-2150